Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1040

2'-fucosyllactose

Intended Use: Intended for use as an ingredient in cow milk-based, exempt infant formula for post-discharge preterm infants at a level up to 2.0 g/L, as consumed.
Basis: Scientific procedures
Notifier: Chr. Hansen A/S
Notifier Address: Boege Allé 10-12
2970 Hoersholm
Denmark
GRAS Notice (releasable information): GRN 1040 (in PDF) (5.7 MB)
Date of closure: Sep 22, 2022
FDA's Letter: At the notifier's request, FDA ceased to evaluate this notice (in PDF) (116 kB)
-
-